Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?
Tariq
S
S
Department of Rheumatology, Hammersmith Hospital, London, UK.
Tariq
S M
SM
D000014:Abnormalities, Drug-Induced; D000019:Abortifacient Agents; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001853:Bone Marrow / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy
D000019:Abortifacient Agents; D008727:Methotrexate